Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-14 Option Award |
2022-06-16 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Bauerlein Alison Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Wicks Timothy A Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:10 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Rajaraman Shivakumar Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:02 pm |
N/A 2028-09-20 |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
15,000 | $0 | 120,234 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:02 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
15,000 | $1 | 120,234 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:45 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | O'Brien Ronan CCO, GC, & Secretary |
166,861 | $0 | 166,861 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:45 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Snow Ellen Chief Accounting Officer |
61,576 | $0 | 61,576 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:44 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | Jeffery Katherine Chief People Officer |
83,431 | $0 | 83,431 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:44 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
119,187 | $0 | 119,187 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:43 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | Maricich Yuri Chief Medical Officer |
166,861 | $0 | 240,481 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:42 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | Strandberg Julia Chief Commercial Officer |
178,780 | $0 | 178,780 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:41 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | GUIFFRE CHRISTOPHERD T CFO, COO, Treas., & Asst. Sec. |
268,170 | $0 | 268,170 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:40 pm |
N/A 2032-02-16 |
Pear Therapeutics Inc. | PEAR | McCann Corey President and CEO |
476,747 | $0 | 11,306,742 (Direct) |
View |
Ownership |
2021-12-13 4:26 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner |
0 | $0 | 18,631,771 (Indirect) |
View |
| 2021-12-08 Option Award |
2021-12-10 4:47 pm |
N/A 2031-12-08 |
Pear Therapeutics Inc. | PEAR | Bauerlein Alison Director |
115 | $0 | 115 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 4:46 pm |
N/A 2031-12-08 |
Pear Therapeutics Inc. | PEAR | Reddy Kirthiga Director |
115 | $0 | 115 (Direct) |
View |
Ownership |
2021-12-09 9:08 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Temasek Holdings (Private) Ltd TLS Beta Pte. Ltd. Temasek Life Sciences Private Ltd Fullerton Management Pte Ltd Elbrus Investments Pte. Ltd. 10% Owner |
0 | $0 | 26,803,573 (Indirect) |
View |
Ownership |
2021-12-08 5:26 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | LJ10 LLC KLP SPAC 1 LLC 10% Owner |
0 | $0 | 17,940,359 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:27 pm |
N/A 2031-12-03 |
Pear Therapeutics Inc. | PEAR | Bauerlein Alison Director |
70,560 | $0 | 70,560 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:26 pm |
N/A 2031-10-29 |
Pear Therapeutics Inc. | PEAR | Gomez Jorge M Director |
70,675 | $0 | 70,675 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:26 pm |
N/A 2031-04-28 |
Pear Therapeutics Inc. | PEAR | Snow Ellen Chief Accounting Officer |
265,034 | $0 | 265,034 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:26 pm |
N/A 2029-09-26 |
Pear Therapeutics Inc. | PEAR | Strandberg Julia Chief Commercial Officer |
780,377 | $0 | 780,377 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:26 pm |
N/A 2030-12-18 |
Pear Therapeutics Inc. | PEAR | SCHLICHTING NANCY M Director |
110,430 | $0 | 110,430 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:25 pm |
N/A 2031-12-03 |
Pear Therapeutics Inc. | PEAR | Reddy Kirthiga Director |
70,560 | $0 | 70,560 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:25 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Schwab Andrew J. Director 10% Owner |
200,000 | $10 | 3,372,769 (Indirect) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:25 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Schwab Andrew J. Director 10% Owner |
18,431,771 | $0 | 3,372,769 (Indirect) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:24 pm |
N/A 2029-06-26 |
Pear Therapeutics Inc. | PEAR | Jeffery Katherine Chief People Officer |
323,930 | $0 | 323,930 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:24 pm |
N/A 2028-09-20 |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
399,987 | $0 | 399,987 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:24 pm |
N/A 2028-03-21 |
Pear Therapeutics Inc. | PEAR | O'Brien Ronan General Counsel & Secretary |
471,168 | $0 | 471,168 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:24 pm |
N/A 2027-12-13 |
Pear Therapeutics Inc. | PEAR | GUIFFRE CHRISTOPHERD T CFO, COO, Treas., & Asst. Sec. |
1,104,306 | $0 | 1,104,306 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:23 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Lynch Zack Director |
10,000 | $10 | 9,711,121 (Indirect) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:23 pm |
N/A 2025-01-21 |
Pear Therapeutics Inc. | PEAR | Lynch Zack Director |
10,786,035 | $0 | 9,711,121 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:23 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | McCann Corey President and CEO |
10,830,086 | $0 | 9,144,173 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:23 pm |
N/A 2025-05-05 |
Pear Therapeutics Inc. | PEAR | Maricich Yuri Chief Medical Officer |
809,823 | $0 | 883,443 (Direct) |
View |